版本:
中国

BRIEF-Merus announces results from MCLA-128 phase 1/2 study

May 17 Merus Nv

* Merus announces promising results from MCLA-128 phase 1/2 study in metastatic breast cancer

* Phase 2 clinical trial to be initiated in second half of 2017 exploring two metastatic breast cancer populations

* Phase 2 study is expected to be launched in Europe and U.S. in second half of 2017 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐